Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVIS

This article was originally published in The Gray Sheet

Executive Summary

Cardiovascular Imaging Systems receives FDA clearance to market the GuideView ultrasound imaging/delivery catheter. The 4 French GuideView incorporates the company's "common-lumen technology which allows low-profile therapeutic and imaging devices to use the distal portion of the catheter interchangeably." CVIS, which does not intend to market the device until late 1994, says it is evaluating use of the device with several angioplasty balloons, including Cordis' Orion and Advanced Cardiovascular Systems' Slalom. CVIS currently is concentrating on ramping up production of its MicroView 2.9 diagnostic catheter, which received FDA clearance on June 29. The company anticipates commercial distribution of the MicroView in October.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT001007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel